Cargando…

Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives

In the last decade, antibody-drug conjugates (ADCs), normally formed by a humanized antibody and a small drug via a chemical cleavable or non-cleavable linker, have emerged as a potential treatment strategy in cancer disease. They allow to get a selective delivery of the chemotherapeutic agents at t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín-Sabroso, Cristina, Lozza, Irene, Torres-Suárez, Ana Isabel, Fraguas-Sánchez, Ana Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541375/ https://www.ncbi.nlm.nih.gov/pubmed/34683998 http://dx.doi.org/10.3390/pharmaceutics13101705

Ejemplares similares

Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)

Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic
por: Fraguas-Sánchez, Ana Isabel, et al.
Publicado: (2022)

Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?
por: Nerone, Marta, et al.
Publicado: (2022)

Development of Innovative Formulations for Breast Cancer Chemotherapy
por: Fraguas-Sánchez, Ana Isabel, et al.
Publicado: (2020)

Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions
por: Mark, Cynthia, et al.
Publicado: (2023)

Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom
por: Pérez-López, Alexandre, et al.
Publicado: (2020)

Sentinel Lymph Node Mapping: Current Applications and Future Perspectives in Gynecology Malignant Tumors
por: Wang, Tianyou, et al.
Publicado: (2022)

PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
por: Fraguas-Sánchez, Ana I., et al.
Publicado: (2020)

The tale of microencapsulated rifampicin: is it useful for the treatment of periprosthetic joint infection?
por: López-Torres, Irene Isabel, et al.
Publicado: (2022)

Amino acids in hematologic malignancies: Current status and future perspective
por: Wang, Mengyao, et al.
Publicado: (2023)

Current Status: Site-Specific Antibody Drug Conjugates
por: Schumacher, Dominik, et al.
Publicado: (2016)

Antibody-drug conjugates: beyond current approvals and potential future strategies
por: Menon, Siddharth, et al.
Publicado: (2022)

Fertility Preservation in Benign Gynecological Diseases: Current Approaches and Future Perspectives
por: Sleiman, Zaki, et al.
Publicado: (2019)

Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans
por: Sahastrabuddhe, Sushant, et al.
Publicado: (2019)

Holm Oak Somatic Embryogenesis: Current Status and Future Perspectives
por: Martínez, María Teresa, et al.
Publicado: (2019)

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
por: Lonial, S, et al.
Publicado: (2016)

Current status and future perspectives of bispecific antibodies in the treatment of lung cancer
por: Wang, Wanying, et al.
Publicado: (2023)

Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
por: Martin, J., et al.
Publicado: (2023)

Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives
por: Motta, Rodrigo, et al.
Publicado: (2021)

Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
por: Anko, Mayuka, et al.
Publicado: (2021)

Polyethylenimine–Bisphosphonate–Cyclodextrin Ternary Conjugates: Supramolecular Systems for the Delivery of Antineoplastic Drugs
por: Plesselova, Simona, et al.
Publicado: (2021)

Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors
por: McNamara, Blair, et al.
Publicado: (2023)

Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
por: Villegas-Pineda, Julio César, et al.
Publicado: (2023)

Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives (†)
por: Hussack, Greg, et al.
Publicado: (2010)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
por: Kardas, Grzegorz, et al.
Publicado: (2022)

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications
por: Willard, Stacey S., et al.
Publicado: (2013)

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
por: Wolska-Washer, Anna, et al.
Publicado: (2023)

Antibody-drug conjugates: Present and future
por: Beck, Alain, et al.
Publicado: (2013)

Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
por: Prince, H. Miles, et al.
Publicado: (2022)

Current status of infrastructures of obstetrics and gynecology in South Korea
por: Park, Yejin, et al.
Publicado: (2015)

Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy
por: Bañón, Sara, et al.
Publicado: (2014)

Monitoring of physical activity promotion in children and adolescents in the EU: current status and future perspectives
por: Marzi, Isabel, et al.
Publicado: (2021)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
por: Chudnova, T., et al.
Publicado: (2022)

Nutrition in Gynecological Diseases: Current Perspectives
por: Ciebiera, Michał, et al.
Publicado: (2021)

The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
por: Simpson, J., et al.
Publicado: (1988)

An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
por: Saga, Tsuneo, et al.
Publicado: (1990)

Antibody Conjugates-Recent Advances and Future Innovations
por: Leung, Donmienne, et al.
Publicado: (2020)

Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature
por: Virarkar, Mayur, et al.
Publicado: (2023)

Disparities in Gynecological Malignancies
por: Chatterjee, Sudeshna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hdk2prtt7radke77rj176939v7